We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPPL:NASDAQSIMPPLE LTD. Analysis

Data as of 2026-05-02 - not real-time

$2.56

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Simpple Ltd. (SPPL) is trading at $2.56, hovering just below its recent resistance around $2.56 while comfortably above the 20‑day and 50‑day moving averages. The 14‑day RSI sits in the mid‑60s, indicating momentum but not yet overbought territory. A bullish MACD crossover, with the MACD line above the signal line and a positive histogram, suggests short‑term upside potential. Volume has been on an upward trend, supporting the technical optimism. However, the price remains well under the 200‑day SMA, which the model flags as a bearish long‑term trend. The market is experiencing extreme greed (Fear & Greed Index 91), potentially inflating speculative buying.
Fundamentally, the company posts deep operating losses (operating margin –88%) and a negative net profit margin of –70%, with no dividend and a negative cash flow profile. Its debt‑to‑equity ratio exceeds 110%, and total debt surpasses cash on hand, creating a fragile balance sheet. The price‑to‑book multiple of nearly 4.7 and a price‑to‑sales ratio above 4 place the stock in an overvalued range relative to its earnings‑light fundamentals. Volatility is exceptionally high at over 100% for the past 30 days, and the historical max drawdown exceeds 70%, underscoring severe price swings. The beta of roughly 0.06 indicates minimal correlation with broader market moves, meaning the stock’s risk is largely idiosyncratic. Recent news that SPPL regained Nasdaq’s minimum bid‑price compliance removes a near‑term regulatory hurdle but does not address the underlying financial weaknesses.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near resistance level
  • bullish MACD crossover
  • increasing trading volume

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • persistent operating losses and negative margins
  • high debt‑to‑equity ratio
  • price below 200‑day SMA indicating bearish long‑term trend

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • extreme volatility and historic max drawdown
  • negative cash flow and ROE
  • overvaluation relative to earnings‑light fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth2.60%
Profit Margin-70.84%
ROE-142.38%
ROA-26.25%
Debt/Equity114.57
P/B Ratio4.7
Op. Cash Flow$-1807519
Free Cash Flow$-3741815
Industry P/E31.2

Technical Analysis

TrendBearish
RSI66.5
Support$1.86
Resistance$2.56
MA 20$2.14
MA 50$2.27
MA 200$3.72
MACDBullish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.06
Volatility109.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.